A Pilot Study of Camrelizumab with Docetaxel and Cisplatin for the First Line Treatment in Recurrent/metastatic Oral Squamous Cell Carcinoma.
MEDCOMM（2023）
Key words
camrelizumab,first-line treatment,immunotherapy,oral cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined